Metabolic Syndrome in Early Onset Versus Late Onset Vitiligo
NCT ID: NCT03622320
Last Updated: 2025-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2018-07-01
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Catecholamines Level in Vitiligo Patients Before and After Excimer Light
NCT04803461
Prevalence of Hepatomegaly in Children and Adolescents With Type 1 Diabetes Mellitus
NCT03666117
Efficacy of Metformin as add-on Therapy in Non-Diabetic Heart Failure Patients
NCT05177588
Novel Classification of Adult-onset Diabetes and Its Association With Common Microvascular Complications in Upper Egypt
NCT04847414
Universal Capillary Screening for Chronic Autoimmune, Metabolic and Cardiovascular Diseases: Feasibility and Acceptability Pilot Study.
NCT05841719
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Since there is temporal relation between nutrition, metabolic derangements and skin diseases where nutritional deficiencies as minerals, vitamins and fatty acids can lead to cutaneous manifestations and , on the other hand; skin diseases could contribute to metabolic derangements and nutritional deficiencies, the investigator's study will focus on nutrition and dietary habits and there possible contribution to any associated metabolic risk in vitiligo patients.
This is likely to open new horizons in the management of vitiligo, possibly through control of metabolic syndrome risk factors and insulin resistance as well as revealing possible temporal relation to dietary habits that are overlooked in vitiligo patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitiligo patients
Vitiligo patients (100 NSV and 50 segmental) who will be further classified according to age of onset and blood sample will be taken
Blood sample
Blood sample for fasting blood sugar (FBS), High density lipoproteins (HDL), Triglycerides (TG) ,HOMA-IR, serum leptin
controls
Matching will be done taking into consideration age, sex, education and socio economic status, blood sample will be taken
Blood sample
Blood sample for fasting blood sugar (FBS), High density lipoproteins (HDL), Triglycerides (TG) ,HOMA-IR, serum leptin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sample
Blood sample for fasting blood sugar (FBS), High density lipoproteins (HDL), Triglycerides (TG) ,HOMA-IR, serum leptin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with non-segmental vitiligo (NSV) and segmental vitiligo
Exclusion Criteria
* Pregnancy
* Systemic steroid intake in the last 6 months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rania Mogawer
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samar El-Tahlawi, MD
Role: PRINCIPAL_INVESTIGATOR
Cairo university, dermatology department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo university hospitals, dermatology outpatient clinic
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ibrahim S, El-Tahlawi S, Mogawer RM, El Ansary M, Esmat S, El-Hawary M. Different vitiligo characteristics as predictors of increased risk of metabolic syndrome and insulin resistance: A case-control study. J Cosmet Dermatol. 2022 Dec;21(12):7170-7177. doi: 10.1111/jocd.15446. Epub 2022 Oct 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Vitiligo & Metabolic syndrome
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.